Flanvotumab, CAS 1188277-05-5

Product Description: Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Khalil DN, et al. An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma. Clin Cancer Res. 2016 Nov 1;22(21):5204-5210.

CAS Number: 1188277-05-5

Molecular Weight: N/A

Compound Purity: 97.83

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Tyrosinase

• Artikelnummer: MEXHY-P99622-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99622-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated